GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biomimetic Therapeutics, Inc. (BMTI) [hlAlert]

Rating:
Buy BMTI
down 31.08 %

Biomimetic Therapeutics, Inc. (BMTI) rated Buy

Posted on: Tuesday,  Oct 9, 2007  9:25 AM ET by Stanford Research

Stanford Research rated Buy Biomimetic Therapeutics, Inc. (NASDAQ: BMTI) on 10/09/2007, when the stock price was $13.77. Since
then, Biomimetic Therapeutics, Inc. has lost 31.08% as of 02/28/2013's recent price of $9.49.
If you would have followed this Stanford Research's recommendation on BMTI, you would have lost 31.08% of your investment in 1969 days.

BioMimetic Therapeutics, Inc. (BioMimetic) develops and commercializes products to stimulate the body?s natural tissue regenerative process. The Company?s protein therapeutic-device combination products are used for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage. The Company?s platform regenerative technology, which incorporates a potent version of one of the body?s natural key stimulators of tissue repair, may offer physicians advanced biological solutions to actively stimulate tissue healing and regeneration. The Company focuses on developing GEM 21S technology to stimulate tissue healing in orthopedic applications (such as distal radius, or wrist, fractures and fusions of the bones in the foot and ankle to eliminate chronic pain from trauma or arthritis), and potentially spine and sports injury applications.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2007 9:25 AM Buy
None
13.77
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD down  -17.04 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy